Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Zhengzhou UniversityActive in the last 2 years

Zhiqiang Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7927-0481; OpenAlex author ID A5101411001. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Identifying drug candidates for pancreatic ductal adenocarcinoma based on integrative multiomics analysis. Co-author DOI 10.21037/jgo-23-985↗
  2. Long non-coding RNA GAS5 antagonizes the chemoresistance of pancreatic cancer cells through down-regulation of miR-181c-5p. Co-author DOI 10.1016/j.biopha.2017.10.157↗
  3. Long non-coding RNA GAS5 suppresses pancreatic cancer metastasis through modulating miR-32-5p/PTEN axis. Co-author DOI 10.1186/s13578-017-0192-0↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huahu Guo · 1 shared paper, 2024 · strength 0.21
  2. Shishi Qiao · 1 shared paper, 2024 · strength 0.21
  3. Huayu Yang · 1 shared paper, 2024 · strength 0.21
  4. Penglei Ge · 1 shared paper, 2024 · strength 0.21
  5. Yang Wu · 1 shared paper, 2024 · strength 0.21
  6. Xiaowei Dang · 2 shared papers, 2017–2018 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.